Your browser doesn't support javascript.
loading
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study.
Ikejiri, Kazuaki; Suzuki, Takafumi; Muto, Satsuki; Takama, Hirotaka; Yamawaki, Kengo; Miyazawa, Tatsuya; Urakawa, Itaru; Aoki, Yuichi; Otsuki, Akihito; Katsuoka, Fumiki; Kinoshita, Kengo; Nangaku, Masaomi; Akizawa, Tadao; Yamamoto, Masayuki.
Afiliación
  • Ikejiri K; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Suzuki T; Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Muto S; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Takama H; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Yamawaki K; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Miyazawa T; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Urakawa I; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Aoki Y; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Otsuki A; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Katsuoka F; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Kinoshita K; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Nangaku M; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Akizawa T; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
  • Yamamoto M; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Clin Exp Nephrol ; 28(3): 225-234, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37962746
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácido Oleanólico / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Insuficiencia Renal Crónica Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácido Oleanólico / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Insuficiencia Renal Crónica Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article